According to our latest study on "Technetium-99m Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis - by Application, End User, and regions" the Technetium-99m Market size was US$ 4.54 billion in 2024 and is expected to reach US$ 6.03 billion by 2031. The Technetium-99m market size is estimated to register a CAGR of 4.2% during 2025-2031.

The Technetium-99m market is segmented into five major regions-North America, Europe, Asia Pacific, Middle East & Africa (MEA) and South America (SAM). North America dominated the market in 2024.

The Asia-Pacific (APAC) Technetium-99m (Tc-99m) market is segmented into key countries including China, India, Japan, Australia, South Korea, and the rest of the region. This market is witnessing rapid growth due to increasing investments in healthcare infrastructure, rising adoption of nuclear medicine, and growing awareness of early disease detection. China is a major driver, with a large patient population, expanding hospitals, and government initiatives supporting advanced diagnostic imaging. India is also experiencing strong growth, fueled by rising healthcare expenditure, growing private diagnostic centers, and increasing prevalence of chronic diseases that require routine imaging. Japan has a mature nuclear medicine sector, with widespread use of Tc-99m in hospitals and diagnostic centers, supported by advanced imaging technology and regulatory frameworks. South Korea is adopting hybrid imaging systems such as SPECT/CT, improving diagnostic precision and clinical efficiency. Australia benefits from well-established healthcare infrastructure and consistent adoption of Tc-99m-based imaging for cardiology, oncology, and bone scans. Other emerging markets in the region, including Southeast Asia, are expanding as healthcare awareness grows and investments in imaging technology increase. Overall, APAC represents a significant opportunity for the Technetium-99m market, driven by increasing patient demand, rising chronic disease burden, and government support for nuclear medicine, making the region a key contributor to global market growth.

The Europe Technetium-99m (Tc-99m) market is gaining strong traction, driven by well-established healthcare infrastructure, increasing demand for advanced diagnostic imaging, and rising prevalence of chronic and age-related diseases. Countries such as Germany, France, the UK, Italy, and Spain are key contributors, supported by widespread adoption of nuclear medicine and advanced imaging technologies like SPECT/CT and SPECT/MRI. Germany leads the market with a large network of hospitals and diagnostic centers investing in hybrid imaging systems, while France and the UK are focusing on improving patient outcomes through more precise and efficient imaging protocols. The growing elderly population in Europe is boosting the demand for routine and specialized imaging procedures, including cardiology, oncology, bone, and neurological scans. Increased awareness of early disease detection and government initiatives promoting the adoption of advanced imaging technologies are further supporting market growth. Additionally, hospitals and diagnostic centers are upgrading their imaging equipment to improve workflow efficiency, reduce scan times, and lower radiation exposure for patients. Emerging tracers and innovations in gamma camera technology, including cadmium-zinc-telluride (CZT) detectors, are enhancing image quality and diagnostic accuracy, encouraging broader use of Tc-99m. Overall, Europe represents a mature and steadily growing market for Tc-99m, combining technological advancements with strong clinical demand to sustain long-term growth.

Key Findings of Technetium-99m Market Study:

By application, the market is segmented into cardiovascular, bone scan, respiratory, tumor imaging, others. The bone scan segment held the largest Technetium-99m market share in 2024. Based on end user, the Technetium-99m market report is divided into hospitals, diagnostic and imaging centers, and others. The hospitals segment dominated the Technetium-99m market share in 2024. Geographically, the Technetium-99m market is segmented into North America, Europe, Asia Pacific, Middle East and Africa (MEA), and South America (SAM).

The Technetium-99m (Tc-99m) market serves a wide range of clinical applications across various medical specialties. In cardiovascular imaging, Tc-99m is extensively used to assess myocardial perfusion, evaluate heart function, and detect coronary artery disease, providing critical information for accurate diagnosis and effective treatment planning. Bone scans are another major application, helping to identify fractures, bone infections, and metastases, offering comprehensive skeletal imaging that supports timely clinical decision-making. In respiratory medicine, Tc-99m is applied in lung ventilation and perfusion imaging, allowing clinicians to evaluate pulmonary function, detect pulmonary embolisms, and monitor other respiratory conditions. Tumor imaging with Tc-99m enables detection, staging, and treatment monitoring of various cancers by highlighting metabolic and functional activity in tumor tissues, facilitating precise evaluation and improved patient outcomes. Beyond these, Tc-99m is also used for imaging other organs such as the liver, kidneys, and thyroid, aiding in diagnosis, therapy monitoring, and disease management across multiple clinical areas. The broad versatility, high diagnostic accuracy, and relatively low radiation dose of Tc-99m make it a preferred choice for healthcare providers worldwide, reinforcing its central role in nuclear medicine and driving continuous growth in its global market.

Lantheus Holdings Inc; Curium; Jubilant Radiopharma; NorthStar Medical Radioisotopes, LLC; Sun RadioPharma (Sun Pharmaceutical Industries, Inc.); NTP Radioisotopes SOC Ltd; Cardinal Health Inc; Medi-Radiopharma; Eckert & Ziegler AG; and Isotope JSC are among the key players profiled in the Technetium-99m market report. Several other major players were studied and analyzed during the Technetium-99m market analysis to get a holistic view of the market and its ecosystem. The Technetium-99m market also provides detailed market insights, which help the key players strategize their growth. The report includes growth prospects owing to the current Technetium-99m market trends and their foreseeable impact during the forecast period.

Contact Us
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com